Nagasaki University Hospital (81005)

Nagasaki, Nagasaki 852-8501

0 studies enrolling now · 2 studies all time

What they study most

C3 Glomerulonephritis, C3 Glomerulopathy, C3G, Complement 3 Glomerulonephritis, Complement 3 Glomerulopathy, Complement 3 Glomerulopathy (C3G), DDD, Dense Deposit Disease, IC-MPGN, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Membranoproliferative Glomerulonephritis, Membranoproliferative Glomerulonephritis (MPGN)

Studies at this site

• An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Running, not enrolling
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed